Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
12.39
+0.54 (4.51%)
Apr 29, 2026, 10:28 AM EDT - Market open

Kazia Therapeutics Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2016
Net Income
-22.8-20.7-26.78-20.47-25.01-8.42
Upgrade
Depreciation & Amortization
-00.931.871.871.871.27
Upgrade
Asset Writedown & Restructuring Costs
13.3813.38----
Upgrade
Loss (Gain) From Sale of Investments
---0.03---
Upgrade
Stock-Based Compensation
4.820.650.531.161.680.64
Upgrade
Other Operating Activities
-7.18-4.534.82-2.05-2.153
Upgrade
Change in Accounts Receivable
3.543.80.013.45-0.01-5.03
Upgrade
Change in Accounts Payable
-4.57-4.9510.740.57-0.531.01
Upgrade
Change in Other Net Operating Assets
0.03-0.11-0.470.581.77-1.09
Upgrade
Operating Cash Flow
-14.4-13.28-9.58-15.16-22.76-9.11
Upgrade
Other Investing Activities
-----2.37-
Upgrade
Investing Cash Flow
-----2.37-
Upgrade
Short-Term Debt Issued
--0.78---
Upgrade
Total Debt Issued
--0.78---
Upgrade
Short-Term Debt Repaid
---0.37---
Upgrade
Total Debt Repaid
---0.37---
Upgrade
Net Debt Issued (Repaid)
--0.41---
Upgrade
Issuance of Common Stock
60.5413.665.9613.374.2229.78
Upgrade
Other Financing Activities
21.032.32-0.38-0.4-0.49-1.67
Upgrade
Financing Cash Flow
81.5615.985.9912.973.7328.11
Upgrade
Foreign Exchange Rate Adjustments
-0.77-0.020.010.061.18-0.18
Upgrade
Net Cash Flow
66.42.69-3.58-2.12-20.2318.82
Upgrade
Free Cash Flow
-14.4-13.28-9.58-15.16-22.76-9.11
Upgrade
Free Cash Flow Margin
-758.36%-725.97%-386.17%-1515600.00%-227620.00%-60.01%
Upgrade
Free Cash Flow Per Share
-6.45-12.12-18.17-41.12-85.92-38.71
Upgrade
Levered Free Cash Flow
1.1-14.915.05-14.62-16.041.26
Upgrade
Unlevered Free Cash Flow
1.1-14.915.05-14.62-16.041.26
Upgrade
Change in Working Capital
-2.61-3.01104.330.86-5.59
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.